These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20687494)

  • 1. Huntington's disease.
    Roze E; Bonnet C; Betuing S; Caboche J
    Adv Exp Med Biol; 2010; 685():45-63. PubMed ID: 20687494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards a transgenic model of Huntington's disease in a non-human primate.
    Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW
    Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
    Shirendeb U; Reddy AP; Manczak M; Calkins MJ; Mao P; Tagle DA; Reddy PH
    Hum Mol Genet; 2011 Apr; 20(7):1438-55. PubMed ID: 21257639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum.
    Mende-Mueller LM; Toneff T; Hwang SR; Chesselet MF; Hook VY
    J Neurosci; 2001 Mar; 21(6):1830-7. PubMed ID: 11245667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Huntington disease. A review].
    Bonilla E
    Invest Clin; 2000 Jun; 41(2):117-41. PubMed ID: 10961047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of G-protein coupled receptors in Huntington's disease.
    Dowie MJ; Scotter EL; Molinari E; Glass M
    Pharmacol Ther; 2010 Nov; 128(2):305-23. PubMed ID: 20708032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective degeneration in YAC mouse models of Huntington disease.
    Van Raamsdonk JM; Warby SC; Hayden MR
    Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic mechanisms in Huntington's disease.
    Jones L; Hughes A
    Int Rev Neurobiol; 2011; 98():373-418. PubMed ID: 21907095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
    Borrell-Pagès M; Zala D; Humbert S; Saudou F
    Cell Mol Life Sci; 2006 Nov; 63(22):2642-60. PubMed ID: 17041811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
    Milnerwood AJ; Cummings DM; Dallérac GM; Brown JY; Vatsavayai SC; Hirst MC; Rezaie P; Murphy KP
    Hum Mol Genet; 2006 May; 15(10):1690-703. PubMed ID: 16600988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective vulnerability of nerve cells in Huntington's disease.
    Sieradzan KA; Mann DM
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile onset Huntington's disease--clinical and research perspectives.
    Nance MA; Myers RH
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):153-7. PubMed ID: 11553930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p75NTR in Huntington's disease: beyond the basal ganglia.
    Brito V; Ginés S
    Oncotarget; 2016 Jan; 7(1):1-2. PubMed ID: 26700963
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.
    Roze E; Betuing S; Deyts C; Marcon E; Brami-Cherrier K; Pagès C; Humbert S; Mérienne K; Caboche J
    FASEB J; 2008 Apr; 22(4):1083-93. PubMed ID: 18029446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and neuropathology of Huntington's disease.
    Reiner A; Dragatsis I; Dietrich P
    Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
    J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of neuronal cell death in Huntington's disease.
    Sawa A; Tomoda T; Bae BI
    Cytogenet Genome Res; 2003; 100(1-4):287-95. PubMed ID: 14526190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's disease: a synaptopathy?
    Li JY; Plomann M; Brundin P
    Trends Mol Med; 2003 Oct; 9(10):414-20. PubMed ID: 14557053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.